| 2019 novel coronavirus (COVID-19) outbreak: a review of the current literature AR Sahin, A Erdogan, PM Agaoglu, Y Dineri, AY Cakirci, ME Senel, ... EJMO 4 (1), 1-7, 2020 | 431 | 2020 |
| Corona virus: a review of COVID-19 D Kumar, R Malviya, PK Sharma EJMO 4 (1), 8-25, 2020 | 148 | 2020 |
| A review of COVID-19 (Coronavirus Disease-2019) diagnosis, treatments and prevention A Hafeez, S Ahmad, SA Siddqui, M Ahmad, S Mishra EJMO 4 (2), 116-125, 2020 | 122 | 2020 |
| Modeling and Forecasting for the number of cases of the COVID-19 pandemic with the Curve Estimation Models, the Box-Jenkins and Exponential Smoothing Methods H Yonar, A Yonar, MA Tekindal, M Tekindal EJMO 4 (2), 160-165, 2020 | 57 | 2020 |
| The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2 RR Narkhede, RS Cheke, JP Ambhore, SD Shinde Eurasian Journal of Medicine and Oncology 4 (3), 185-195, 2020 | 51 | 2020 |
| Cytokine-targeted therapy in severely ill COVID-19 patients: options and cautions M Rahmati, MA Moosavi mortality 105954, 2020 | 36 | 2020 |
| Frequency of RAS mutations (KRAS, NRAS, HRAS) in human solid cancer H Kodaz, O Kostek, MB Hacioglu, B Erdogan, CE Kodaz, I Hacibekiroglu, ... Breast cancer 7 (12), 1-7, 2017 | 30 | 2017 |
| Case fatality rate estimation of COVID-19 for European countries: Turkey’s current scenario amidst a global pandemic; comparison of outbreaks with European countries F Öztoprak, A Javed ejmo 21, 24, 2020 | 28 | 2020 |
| In Silico approach of some selected honey constituents as SARS-CoV-2 main protease (COVID-19) inhibitors H Hashem | 20 | 2020 |
| Genome organization of Covid-19 and emerging severe acute respiratory syndrome Covid-19 outbreak: a pandemic HS Dagur, SS Dhakar EJMO 4 (2), 107-115, 2020 | 19 | 2020 |
| Why are Children Less Affected by COVID-19 ? Could there be an Overlooked Bacterial Co-Infection? MT Ramazan Azim Okyay, Ahmet Rıza Sahin, Rene A. Aguinada Eurasian Journal of Medicine and Oncology 4 (1), 104-105, 2020 | 16* | 2020 |
| The rise of new coronavirus infection-(COVID-19): a recent update SN Mali, AP Pratap, BR Thorat Eurasian Journal of Medicine and Oncology 4 (1), 35-41, 2020 | 12 | 2020 |
| The rise of new coronavirus infection-(COVID-19): a recent update SN Mali, AP Pratap, BR Thorat Eurasian Journal of Medicine and Oncology 4 (1), 35-41, 2020 | 12 | 2020 |
| Successful treatment strategy of Turkey against COVID-19 outbreak H Kodaz EJMO 4 (2), 177-8, 2020 | 10 | 2020 |
| The impacts of covariates on spatial distribution of corona virus 2019 (COVID-19): what do the data show through ANCOVA and MANCOVA HT Likassa EJMO 4 (2), 141-148, 2020 | 10 | 2020 |
| Computed Tomography Organ Dose Determination Using ImPACT Simulation Software: Our Findings In South-West Nigeria JCE MO Akpochafor, AD Omojola, MY Habeebu Eurasian journal of medicine and oncology https://www.ejmo.org/10.14744 …, 2018 | 8* | 2018 |
| Recombinant human angiotensin-converting enzyme 2 and COVID-19 acute respiratory distress syndrome: a theoretical or a real resource M Barone, C Ucciferri, G Cipollone, F Mucilli Ejmo 4 (2), 139-140, 2020 | 7 | 2020 |
| Vitamin D deficiency and toxicity SM Buyuker Eurasian J Med Oncol 3 (1), 1-5, 2019 | 7 | 2019 |
| The prevalence of insulin resistance in the Turkish population: a study conducted with 3331 participants A Kaya, E Turan, M Uyar, F Bayram, Y Turan EJMO 1 (4), 202-206, 2017 | 6 | 2017 |
| Various evidence-based hypothetical and experimental treatment approaches and their effectiveness against COVID-19 worldwide: a comprehensive literature review M Naveed, S Uddin, KS Abdullah, SE Ishaq, T Ahmad Eurasian J Med Oncol 4, 265-285, 2020 | 5 | 2020 |
